For patients with vitiligo, extended treatment with narrowband ultraviolet B (UVB) phototherapy does not lead to an increase in their risk of developing skin cancer, according to a new study. The study, published online ahead of print in JAMA Dermatology (Mar. 11, 2020), took a deeper look at UVB phototherapy, which is often used for vitiligo patients.